open access

Vol 4, No 2 (2019)
CASE REPORTS
Published online: 2019-03-22
Get Citation

Gastrointestinal bleeding and the prevention of thromboembolism

Aušra Marcinkonytė, Daiva Emilija Rekienė, Jonas Jucevičius, Laima Jankauskienė
DOI: 10.5603/MRJ.a2019.0018
·
Medical Research Journal 2019;4(2):116-119.

open access

Vol 4, No 2 (2019)
CASE REPORTS
Published online: 2019-03-22

Abstract

About 2 percent of developed countries population use vitamin K antagonists (VKA), such as warfarin.
These anticoagulation drugs are commonly prescribed for the purpose of thromboembolism prevention,
in cases of atrial fibrillation, mechanical heart valves, deep vein thrombosis, pulmonary embolism and
etc. The frequency of VKA prescription is massively increasing in the whole world. The main reason for
it is the ageing of the population. As the usage of anticoagulants is increasing, doctors more often get
to encounter patients with gastrointestinal bleeding taking anticoagulating drugs. The treatment of these
patients is difficult because there are several important factors that have to be considered while choosing
the tactic of treatment, such as the intensity of bleeding, coagulation, thrombotic risk and endoscopic
findings. Even if practical guidelines partially indicate the main principles of actions for similar cases, the
treatment of bleeding patients taking anticoagulants remains seriously challenging. This article contains
clinical case report and the discussion of the treatment that has been chosen in this case, based on
practical guidelines provided by American Society for Gastrointestinal Endoscopy (ASGE), European
Society of Gastrointestinal Endoscopy (ESGE) and European Society of Cardiology (ESC). This topic is
also addressed in guidelines from the American College of Gastroenterology, the American College of
Chest Physicians, the American College of Cardiology, which give similar recommendations.

Abstract

About 2 percent of developed countries population use vitamin K antagonists (VKA), such as warfarin.
These anticoagulation drugs are commonly prescribed for the purpose of thromboembolism prevention,
in cases of atrial fibrillation, mechanical heart valves, deep vein thrombosis, pulmonary embolism and
etc. The frequency of VKA prescription is massively increasing in the whole world. The main reason for
it is the ageing of the population. As the usage of anticoagulants is increasing, doctors more often get
to encounter patients with gastrointestinal bleeding taking anticoagulating drugs. The treatment of these
patients is difficult because there are several important factors that have to be considered while choosing
the tactic of treatment, such as the intensity of bleeding, coagulation, thrombotic risk and endoscopic
findings. Even if practical guidelines partially indicate the main principles of actions for similar cases, the
treatment of bleeding patients taking anticoagulants remains seriously challenging. This article contains
clinical case report and the discussion of the treatment that has been chosen in this case, based on
practical guidelines provided by American Society for Gastrointestinal Endoscopy (ASGE), European
Society of Gastrointestinal Endoscopy (ESGE) and European Society of Cardiology (ESC). This topic is
also addressed in guidelines from the American College of Gastroenterology, the American College of
Chest Physicians, the American College of Cardiology, which give similar recommendations.

Get Citation

Keywords

anticoagulants, warfarin, bleeding, thromboembolism, anticoagulation, endoscopy

About this article
Title

Gastrointestinal bleeding and the prevention of thromboembolism

Journal

Medical Research Journal

Issue

Vol 4, No 2 (2019)

Pages

116-119

Published online

2019-03-22

DOI

10.5603/MRJ.a2019.0018

Bibliographic record

Medical Research Journal 2019;4(2):116-119.

Keywords

anticoagulants
warfarin
bleeding
thromboembolism
anticoagulation
endoscopy

Authors

Aušra Marcinkonytė
Daiva Emilija Rekienė
Jonas Jucevičius
Laima Jankauskienė

References (10)
  1. Radaelli F, Dentali F, Repici A, et al. Management of anticoagulation in patients with acute gastrointestinal bleeding. Dig Liver Dis. 2015; 47(8): 621–627.
  2. Gutermann IK, Niggemeier V, Zimmerli LU, et al. Gastrointestinal bleeding and anticoagulant or antiplatelet drugs: systematic search for clinical practice guidelines. Medicine (Baltimore). 2015; 94(1): e377.
  3. Hull DR, Garcia DA. Management of warfarin-associated bleeding or supratherapeutic INR. https://www-uptodate-com.ezproxy.dbazes.lsmuni.lt/contents/management-of-warfarin-associated-bleeding-or-supratherapeutic-inr?sectionName=Serious%2Flife-threatening%20bleeding&topicRef=104830&anchor=H744870&source=see_link#H744870. (Jan 02, 2019).
  4. Acosta RD, Abraham NS, Chandrasekhara V, et al. ASGE Standards of Practice Committee. The management of antithrombotic agents for patients undergoing GI endoscopy. Gastrointest Endosc. 2016; 83(1): 3–16.
  5. Saltzman JR. Approach to acute upper gastrointestinal bleeding in adults. https://www-uptodate-com.ezproxy.dbazes.lsmuni.lt/contents/approach-to-acute-upper-gastrointestinal-bleeding-in-adults?search=practical%20guidlines%20for%20gastrointestinal%20bleeding%20and%20anticoagulation%20therapy&source=search_result&selectedTitle=5~150&usage_type=default&display_rank=5#H5079756. (Jan 10, 2019).
  6. Kamath PS. Management of anticoagulants in patients undergoing endoscopic procedures. https://www-uptodate-com.ezproxy.dbazes.lsmuni.lt/contents/management-of-anticoagulants-in-patients-undergoing-endoscopic-procedures?sectionName=URGENT%20PROCEDURES&topicRef=2547&anchor=H12&source=see_link#H15. ( Dec 03, 2018).
  7. Douketis JD, Lip G. Perioperative management of patients receiving anticoagulants. https://www-uptodate-com.ezproxy.dbazes.lsmuni.lt/contents/perioperative-management-of-patients-receiving-anticoagulants?sectionName=BRIDGING%20ANTICOAGULATION&topicRef=2609&anchor=H2126501&source=see_link#H2126501. (Sep 24, 2018).
  8. Gaasch WH, Konkle BA. Antithrombotic therapy for prosthetic heart valves: Management of bleeding and invasive procedures. https://www-uptodate-com.ezproxy.dbazes.lsmuni.lt/contents/antithrombotic-therapy-for-prosthetic-heart-valves-management-of-bleeding-and-invasive-procedures?sectionName=With%20risk%20factors%20for%20thrombosis&topicRef=8171&anchor=H919063611&source=see_link#H919063611. (Aug 15, 2016).
  9. Babarskienė MR, Bakšytė G, Baronaitė- Dū, et al. Širdies ligų gydymas (algoritmai ir schemos). 3rd ed. Kaunas: UAB "Kardiologijos projektai. ; 2011.
  10. Halvorsen S, Storey RF, Rocca B, et al. ESC Working Group on Thrombosis. Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis. Eur Heart J. 2017; 38(19): 1455–1462.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.